Global Next Generation Sequencing Ngs Market Companies

Medical Devices
Apr 2025
Global
350 Pages
No of Tables: 825
No of Figures: 40

Buy Now

Request for Sample

Nucleus

Companies Covered

Highest Market Share

Dominant Companies

Other Companies

Global Next Generation Sequencing Ngs Market Share Analysis

The data presented is for visualization purposes only and may not reflect actual results.

Nucleus : Company Analysis Platform

Request for Demo >

Frequently Asked Questions

Who are major players in next generation sequencing (NGS) market?

Companies such as Illumina, Inc. (U.S.), Thermo Fisher Scientific (U.S.), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies (U.K.), BGI Group (China), MGI Tech (China), Roche Sequencing Solutions (Switzerland), are the major players in the next generation sequencing (NGS) market.

What are the recent product launches by major companies in the next generation sequencing (NGS) market?

In April 2024, Merck KGaA announced the launch of the industry’s first comprehensive and validated genetic stability assay, marking a significant advancement in biomanufacturing safety. The newly introduced Aptegra CHO Genetic Stability Assay integrates whole genome sequencing with advanced bioinformatics, offering a streamlined approach to genetic stability testing.

Which countries data is covered in the next generation sequencing (NGS) market?

The countries covered in the next generation sequencing (NGS) market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.